These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32241199)

  • 1. Global optimization of the Michaelis-Menten parameters using physiologically-based pharmacokinetic (PBPK) modeling and chloroform vapor uptake data in F344 rats.
    Evans MV; Eklund CR; Williams DN; Sey YM; Simmons JE
    Inhal Toxicol; 2020 Feb; 32(3):97-109. PubMed ID: 32241199
    [No Abstract]   [Full Text] [Related]  

  • 2. Applications of sensitivity analysis to a physiologically based pharmacokinetic model for carbon tetrachloride in rats.
    Evans MV; Crank WD; Yang HM; Simmons JE
    Toxicol Appl Pharmacol; 1994 Sep; 128(1):36-44. PubMed ID: 8079352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Closed-chamber inhalation pharmacokinetic studies with hexamethyldisiloxane in the rat.
    Dobrev ID; Reddy MB; Plotzke KP; Varaprath S; McNett DA; Durham J; Andersen ME
    Inhal Toxicol; 2003 May; 15(6):589-617. PubMed ID: 12692732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A distributed parameter physiologically-based pharmacokinetic model for dermal and inhalation exposure to volatile organic compounds.
    Roy A; Weisel CP; Lioy PJ; Georgopoulos PG
    Risk Anal; 1996 Apr; 16(2):147-60. PubMed ID: 8638037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian estimation of pharmacokinetic and pharmacodynamic parameters in a mode-of-action-based cancer risk assessment for chloroform.
    Liao KH; Tan YM; Conolly RB; Borghoff SJ; Gargas ML; Andersen ME; Clewell HJ
    Risk Anal; 2007 Dec; 27(6):1535-51. PubMed ID: 18093051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a physiologically based pharmacokinetic model for chlorobenzene in F-344 rats.
    Thrall KD; Woodstock AD; Kania MR
    J Toxicol Environ Health A; 2004 Apr; 67(7):525-36. PubMed ID: 15129550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visualization-based analysis for a mixed-inhibition binary PBPK model: determination of inhibition mechanism.
    Isaacs KK; Evans MV; Harris TR
    J Pharmacokinet Pharmacodyn; 2004 Jun; 31(3):215-42. PubMed ID: 15518245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative metabolism of carbon tetrachloride in rats, mice, and hamsters using gas uptake and PBPK modeling.
    Thrall KD; Vucelick ME; Gies RA; Zangar RC; Weitz KK; Poet TS; Springer DL; Grant DM; Benson JM
    J Toxicol Environ Health A; 2000 Aug; 60(8):531-48. PubMed ID: 10983521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiologically based pharmacokinetic estimated metabolic constants and hepatotoxicity of carbon tetrachloride after methanol pretreatment in rats.
    Evans MV; Simmons JE
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):245-53. PubMed ID: 8887440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing interaction thresholds for trichloroethylene in combination with tetrachloroethylene and 1,1,1-trichloroethane using gas uptake studies and PBPK modeling.
    Dobrev ID; Andersen ME; Yang RS
    Arch Toxicol; 2001 May; 75(3):134-44. PubMed ID: 11409535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a physiologically based pharmacokinetic model for methyl ethyl ketone in F344 rats.
    Thrall KD; Soelberg JJ; Weitz KK; Woodstock AD
    J Toxicol Environ Health A; 2002 Jul; 65(13):881-96. PubMed ID: 12133235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of an updated physiologically based pharmacokinetic model for chloroform to evaluate CYP2E1-mediated renal toxicity in rats and mice.
    Sasso AF; Schlosser PM; Kedderis GL; Genter MB; Snawder JE; Li Z; Rieth S; Lipscomb JC
    Toxicol Sci; 2013 Feb; 131(2):360-74. PubMed ID: 23143927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a physiologically based pharmacokinetic model to identify exposures consistent with human biomonitoring data for chloroform.
    Tan YM; Liao KH; Conolly RB; Blount BC; Mason AM; Clewell HJ
    J Toxicol Environ Health A; 2006 Sep; 69(18):1727-56. PubMed ID: 16864423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing kinetic determinants for metabolism and oral uptake of octamethylcyclotetrasiloxane (D4) from inhalation chamber studies.
    Dobrev ID; Nong A; Liao KH; Reddy MB; Plotzke KP; Andersen ME
    Inhal Toxicol; 2008 Feb; 20(4):361-73. PubMed ID: 18302045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a hybrid computational fluid dynamics and physiologically based inhalation model for interspecies dosimetry comparisons of ester vapors.
    Frederick CB; Lomax LG; Black KA; Finch L; Scribner HE; Kimbell JS; Morgan KT; Subramaniam RP; Morris JB
    Toxicol Appl Pharmacol; 2002 Aug; 183(1):23-40. PubMed ID: 12217639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A physiologically based pharmacokinetic model for trichloroethylene in the male long-evans rat.
    Simmons JE; Boyes WK; Bushnell PJ; Raymer JH; Limsakun T; McDonald A; Sey YM; Evans MV
    Toxicol Sci; 2002 Sep; 69(1):3-15. PubMed ID: 12215655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a physiologically based pharmacokinetic model for inhalation of jet fuels in the rat.
    Martin SA; Campbell JL; Tremblay RT; Fisher JW
    Inhal Toxicol; 2012 Jan; 24(1):1-26. PubMed ID: 22188408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer simulation of the lactational transfer of tetrachloroethylene in rats using a physiologically based model.
    Byczkowski JZ; Kinkead ER; Leahy HF; Randall GM; Fisher JW
    Toxicol Appl Pharmacol; 1994 Apr; 125(2):228-36. PubMed ID: 8171430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and modeling of the impact of coexposures to VOC mixtures on urinary biomarkers.
    Marchand A; Aranda-Rodriguez R; Tardif R; Nong A; Haddad S
    Inhal Toxicol; 2016; 28(6):260-73. PubMed ID: 27053005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a physiologically based pharmacokinetic model for decane, a constituent of jet propellent-8.
    Perleberg UR; Keys DA; Fisher JW
    Inhal Toxicol; 2004; 16(11-12):771-83. PubMed ID: 16036747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.